EX-FILING FEES 5 d383770dexfilingfees.htm EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Amylyx Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities and Carry Forward Securities

|  | Security type |  | Security class title |  | Fee calculation or carry forward rule |  | Amount registered |  | Proposed maximum offering price per share |  | Proposed maximum aggregate offering price(1)(2) |  | Fee rate |  | Amount of registration fee (3)
Newly Registered Securities
Fees to Be Paid |  | Equity |  | Common Stock, par value $0.0001 per share |  | 457(o) |  | — |  | — |  | $205,275,000 |  | 0.0001102 |  | $22,621.31
Fees Previously Paid |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | —
Carry Forward Securities
Carry Forward Securities |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | —
|  | Total Offering Amounts |  |  |  | $205,275,000 |  |  |  | $22,621.31
|  | Total Fees Previously Paid |  |  |  |  |  |  |  | —
|  | Total Fee Offsets |  |  |  |  |  |  |  | —
|  | Net Fee Due |  |  |  |  |  |  |  | $22,621.31

(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.

(2) | Includes the offering price of shares that the underwriters may purchase pursuant to an option to purchase additional shares.

(3) | Calculated pursuant to Rule 457(o) based on an estimate of the proposed maximum aggregate offering price.